Good Neighbor PharmacyFranchise Cost, Revenue & Review 2026
Data from FDD filing + SBA 7(a) records
FranchiseVerdict summary · 2026
A Good Neighbor Pharmacy franchise requires a total initial investment of $44K – $575K. The 2026 FDD does not disclose unit-level revenue (no Item 19). SBA 7(a) loans show a 0.0% charge-off rate across 11 loans[1]. Verdict grade: A. Run a live ROI scan →
Data last verified June 18, 2026 · figures per the 2026 FDD issuance
Overview
- Investment
- $44K – $575K
- 6th pct Healthcare
- Avg gross sales
- N/A
- 48th pct Healthcare
- Royalty
- N/A
- Units
- 2,361
- 77th pct Healthcare
- SBA default
- 0.0%
- system-wide median varies by category
Quick verdict · Healthcare · color = vs category peers
Green = >15% above Healthcare avg · No shading = within ±15% · Red = >15% below avg · Source: FDD filings + SBA 7(a)
Data from public FDD filings and SBA records. Not financial advice. Methodology
Only 0.0% of 11 SBA loans charged off, well below the 16% franchise average.
Franchised units fell from 2497 to 2361 over 3 years. Investigate why operators are leaving.
Large franchise systems benefit from brand recognition, supply chain leverage, and proven operations.
Bottom line
- Total investment $44K – $575K including a $0 franchise fee.
- Item 19 discloses "comparative performance metrics" rather than annual gross sales, so unit revenue is not directly comparable.
- Verdict A (Top Quintile) with a risk score of 35/100. SBA loan charge-off rate of 0.0% across 11 loans (well below the franchise average, based on all SBA 7(a) franchise lending, 2010–2024).
- System contracting at -5.4% CAGR over 3 years. Investigate whether closures are franchisor-driven (consolidation) or franchisee-driven (economics).
Item 1 · who you're contracting with
The Franchisor
- Legal entity
- AmerisourceBergen Drug Corporation
- Parent company
- Cencora, Inc.
- Incorporated in
- DE
- HQ
- 1 West First Avenue, Conshohocken, PA, 19428
- Auditor
- Ernst & Young LLP
- Audited financials
Overview
About
Good Neighbor Pharmacy franchisees operate community pharmacies focused on prescription filling, medication counseling, and retail health products. Day-to-day operations include managing pharmacy staff, handling prescription intake and insurance claims, dispensing medications, and competing with major chains and mail-order services. Franchisees depend on franchisor support for compliance, purchasing power, and operational systems.
- CEO
- Robert P. Mauch
- Founded
- 1985
- FDD year
- 2026
- States available
- 51
FDD Item 7 · 2026 filing
Initial investment breakdown
| Cost component | Low | High |
|---|---|---|
| Working capital (3–6 mo) | $40K | $150K |
| Equipment, build-out, other | $4K | $425K |
| Total initial investment | $44K | $575K |
Source: Good Neighbor Pharmacy 2026 FDD, Items 5 and 7[2]. “Equipment, build-out, other” is computed as total minus disclosed line items above.
Item 7 · what it costs to open + operate
The Vitals
- Total investment
- $44K – $575K
- Better than avg vs category
- Liquid capital req'd
- $40K – $150K
- Near category avg vs category
- Franchise fee
- N/A
- Better than avg vs category
- Royalty
- $599 per month
- Ad fund
- -n/d
Financial Performance
This brand's FDD disclosed "comparative performance metrics" in Item 19 rather than annual gross sales. This metric cannot be directly compared across brands, so we omit it from rankings.
vs Healthcare averages
How Good Neighbor Pharmacy Compares
Unit growth
Item 20 · unit dynamics
The Growth Chart
- Total units
- 2,361
- Opened
- 174
- Last reporting year
- Closed
- 264
- Turnover rate
- 11.2%
- Company-owned
- 0
- Corporate units in the system
- % franchised
- 100%
- vs corporate-owned
- Net growth (yr3)
- -4.6%
- Net unit change last year
- 3-yr CAGR
- -5.4%
- Compounded over last 3 years
3-year detail · Item 20
- Transfers (3yr)
- 45
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 20 · 24 states with active franchisees
The Territory Map
Derived from franchisee contact records. Shows states with at least one current operator. Not where the franchisor is registered to sell new units (that data is re-extracting in a future refresh).
States derived from franchisee contact records (FDD Item 20). Shows states with at least one current operator on file. Full state registration data (Item 12) will appear on a future FDD refresh.
SBA loan performance
Government records
SBA Loan Data
Aggregated from SBA 7(a) and 504 loan disclosures, public data unique to FranchiseVerdict.
- Total loans
- 11
- Loan volume
- $23.1M
- Median loan
- $1.9M
- 50th percentile
- Charge-off rate
- 0.0%
- rates vary by category · see methodology
Historical SBA 7(a) lending data, not predictive of future performance. How SBA charge-off rates are calculated
- Repayment rate (PIF)
- 100.0%
- 5-yr charge-off
- N/A
- Loans approved 2021+
- Active lenders
- 5
- Defaults
- 0
Explore lender portfolios on Bank Reports or regional data on State Reports.
Premium insight
SBA Lending Report
Deep-dive into Good Neighbor Pharmacy's SBA lending history: lender network, geographic footprint, interest rates, and more.
SBA Lending Report
- Principal loss rate and NAICS industry benchmark
- 5 lenders with concentration factor
- Per-state charge-off rates across 8 states
- Startup risk premium and job creation velocity
- 6-year lending trend
- SBA 504 real estate/equipment data
Instant access. No subscription.
With a 0.0% charge-off rate across 11 loans, banks have historically viewed this brand favorably for lending.
Risk analysis
FranchiseVerdict rating + FDD Items 3, 5, 6, 12, 17
Risk & Legal
High-risk investment in declining pharmacy franchise with severe regulatory/litigation exposure, going concern doubts, shrinking unit base, and opaque financial disclosure.
Audited financials (Item 21)
Yes · Ernst & Young LLP
Score breakdown · what drove the 35 / 100 rating
- 01MINORDeclining unit count (2,361 units, -4.6% YoY) indicates contracting franchise system with potential saturation or performance issues
- 02HIGHExtensive litigation history including False Claims Act settlements, opioid distribution MDL settlements, public nuisance verdict, and DOJ Controlled Substances Act violations creates significant legal and operational risk
- 03HIGHGoing Concern status is FALSE — indicates substantial doubt about franchisor's ability to continue operations, threatening franchisee support and brand viability
- 04MINORNo average revenue or net income disclosure (Item 19) prevents prospective franchisees from assessing realistic earning potential and ROI
- 05MINORUnprotected territory with $599 monthly royalty creates competitive vulnerability; franchisor can saturate your market without compensation
- 06MINORWide investment range ($43,797 – $575,205) suggests highly variable unit economics and unclear capital requirements
- 07MEDZero franchise fee indicates potential financial weakness of franchisor and limited resources for franchisee support and system development
Severity inferred from the FDD text · not a regulatory classification
FDD Items 5, 6, 12, 17 · continued from Risk & Legal
Contract & Territory Detail
| Initial term | 5 years |
|---|---|
| Renewal term | 2 years |
| Protected territory | No |
| Online sales rights | Granted |
| Franchisor can compete | Yes |
| Hire a manager? | Allowed |
| Owner-operator | Required |
| Right of first refusalℹ | No |
| Termination notice | 60 days |
| Mandatory arbitration | Yes |
| Jury trial waiver | Yes |
| Governing law | Pennsylvania |
| Litigation count | 8 |
Items 10, 11
Training & Operations
- Classroom training
- 0 hrs
- On-the-job training
- 0 hrs
Items 5 & 11
Franchisor Support
Item 20 · call current owners
Franchisee Contacts
141 owners to call
Name · phone · city · state. Extracted from FDD Item 20
FDD download
Good Neighbor Pharmacy · FDD (2026) PDF
Frequently asked questions
Frequently Asked Questions
How much does it cost to open a Good Neighbor Pharmacy franchise?
The total investment to open a Good Neighbor Pharmacy franchise ranges from $44K – $575K. This includes real estate, equipment, inventory, and working capital as disclosed in their Franchise Disclosure Document (FDD).
What do Good Neighbor Pharmacy franchise owners earn?
Good Neighbor Pharmacy does not disclose average franchise owner earnings in their FDD Item 19. Not all franchisors are required to make financial performance representations. We recommend asking existing franchisees directly about their financial experience.
What is Good Neighbor Pharmacy's franchise failure rate?
Based on SBA 7(a) loan data, Good Neighbor Pharmacy has a charge-off rate of 0.0% across 11 loans, meaning 0.0% of franchise loans were charged off. Charge-off rates are one proxy for franchise risk, though they do not capture all closures. This data comes from FOIA-sourced SBA lending records.
How many Good Neighbor Pharmacy franchise locations are there?
As of their most recent FDD filing, Good Neighbor Pharmacy has 2,361 total units in the United States, including 2,497 franchised units and 0 company-owned units. 174 new units were opened in the latest reporting year.
Is Good Neighbor Pharmacy a good franchise to buy?
FranchiseVerdict rates Good Neighbor Pharmacy as a A-grade franchise with a risk score of 35 out of 100, based on our analysis of investment costs, revenue data, SBA loan performance, and growth trends. Our rating is based solely on publicly available FDD and government data; we recommend speaking with current franchisees before making any investment decision. This is not investment advice.
Data sourced from public FDD filings and SBA 7(a) FOIA records. Not financial advice.
For franchisors
Are you the franchisor?
If you represent Good Neighbor Pharmacy, you can request corrections or provide updated information.
Claim this brandOther Healthcare franchises
Compare similar franchise opportunities in the Healthcare category
Data extracted from public FDD filings and SBA 7(a) loan disclosures (FOIA). This information is provided for research purposes only and does not constitute financial, legal, or investment advice. Verify all figures with the franchisor's current Franchise Disclosure Document before making any investment decision.